SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Heron Therapeutics, Inc./DE – ‘10-Q’ for 3/31/15 – ‘XML’

On:  Friday, 5/8/15, at 3:23pm ET   ·   For:  3/31/15   ·   Accession #:  1193125-15-179414   ·   File #:  1-33221

Previous ‘10-Q’:  ‘10-Q’ on 11/6/14 for 9/30/14   ·   Next:  ‘10-Q’ on 8/7/15 for 6/30/15   ·   Latest:  ‘10-Q’ on 5/7/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/08/15  Heron Therapeutics, Inc./DE       10-Q        3/31/15   38:2.1M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    164K 
 2: EX-10.1     Material Contract                                   HTML     20K 
 3: EX-10.2     Material Contract                                   HTML     20K 
 4: EX-10.3     Material Contract                                   HTML     15K 
 5: EX-10.4     Material Contract                                   HTML     18K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
24: R1          Document And Entity Information                     HTML     39K 
19: R2          Condensed Consolidated Balance Sheets (Current      HTML     76K 
                Period Unaudited)                                                
22: R3          Condensed Consolidated Statements of Operations     HTML     38K 
                (Unaudited)                                                      
26: R4          Condensed Consolidated Statements of Cash Flows     HTML     76K 
                (Unaudited)                                                      
34: R5          Note 1 - Business                                   HTML     31K 
20: R6          Note 2 - Basis of Presentation                      HTML     18K 
21: R7          Note 3 - Accounting Policies                        HTML     37K 
18: R8          Note 4 - Convertible Notes to Related Parties       HTML     23K 
16: R9          Note 5 - Stockholders' Equity                       HTML     79K 
35: R10         Note 6 - Income Taxes                               HTML     20K 
28: R11         Significant Accounting Policies (Policies)          HTML     52K 
27: R12         Note 3 - Accounting Policies (Tables)               HTML     23K 
31: R13         Note 5 - Stockholders' Equity (Tables)              HTML     64K 
32: R14         Note 1 - Business (Details Textual)                 HTML     24K 
30: R15         Note 3 - Accounting Policies - Equity Excluded      HTML     25K 
                From Calculation of Diluted Earnings Per Share                   
                (Details)                                                        
33: R16         Note 4 - Convertible Notes to Related Parties       HTML     66K 
                (Details Textual)                                                
23: R17         Note 5 - Stockholders' Equity (Details Textual)     HTML     94K 
25: R18         Note 5 - Stockholders' Equity - Allocation of the   HTML     24K 
                Recognized Cost (Details)                                        
29: R19         Note 5 - Stockholders' Equity - Option Valuation    HTML     26K 
                Assumptions (Details)                                            
38: R20         Note 5 - Stockholders' Equity - Option Summary      HTML     40K 
                (Details)                                                        
37: XML         IDEA XML File -- Filing Summary                      XML     49K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX     56K 
17: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    261K 
 9: EX-101.INS  XBRL Instance -- hrtx-20150331                       XML    390K 
11: EX-101.CAL  XBRL Calculations -- hrtx-20150331_cal               XML     53K 
12: EX-101.DEF  XBRL Definitions -- hrtx-20150331_def                XML    382K 
13: EX-101.LAB  XBRL Labels -- hrtx-20150331_lab                     XML    358K 
14: EX-101.PRE  XBRL Presentations -- hrtx-20150331_pre              XML    391K 
10: EX-101.SCH  XBRL Schema -- hrtx-20150331                         XSD     65K 
36: ZIP         XBRL Zipped Folder -- 0001193125-15-179414-xbrl      Zip     53K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<Version> 2.4.1.9 </Version>
<ProcessingTime/>
<ReportFormat> Html </ReportFormat>
<ContextCount> 49 </ContextCount>
<ElementCount> 116 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 16 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000 - Document - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-document-and-entity-information </Role>
<ShortName> Document And Entity Information </ShortName>
</Report>
<Report>
<IsDefault> true </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited </Role>
<ShortName> Condensed Consolidated Balance Sheets (Current Period Unaudited) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 002 - Statement - Condensed Consolidated Statements of Operations (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-condensed-consolidated-statements-of-operations-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Operations (Unaudited) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 003 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows (Unaudited) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 004 - Disclosure - Note 1 - Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-1-business </Role>
<ShortName> Note 1 - Business </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 005 - Disclosure - Note 2 - Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-2-basis-of-presentation </Role>
<ShortName> Note 2 - Basis of Presentation </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 006 - Disclosure - Note 3 - Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-3-accounting-policies </Role>
<ShortName> Note 3 - Accounting Policies </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 007 - Disclosure - Note 4 - Convertible Notes to Related Parties </LongName>
<ReportType> Notes </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-4-convertible-notes-to-related-parties </Role>
<ShortName> Note 4 - Convertible Notes to Related Parties </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 008 - Disclosure - Note 5 - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity </Role>
<ShortName> Note 5 - Stockholders' Equity </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 009 - Document - Note 6 - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-6-income-taxes </Role>
<ShortName> Note 6 - Income Taxes </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 010 - Disclosure - Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-significant-accounting-policies-policies </Role>
<ShortName> Significant Accounting Policies (Policies) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 011 - Disclosure - Note 3 - Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-3-accounting-policies-tables </Role>
<ShortName> Note 3 - Accounting Policies (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 012 - Disclosure - Note 5 - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity-tables </Role>
<ShortName> Note 5 - Stockholders' Equity (Tables) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 013 - Disclosure - Note 1 - Business (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-1-business-details-textual </Role>
<ShortName> Note 1 - Business (Details Textual) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 014 - Statement - Note 3 - Accounting Policies - Equity Excluded From Calculation of Diluted Earnings Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-3-accounting-policies-equity-excluded-from-calculation-of-diluted-earnings-per-share-details </Role>
<ShortName> Note 3 - Accounting Policies - Equity Excluded From Calculation of Diluted Earnings Per Share (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 015 - Disclosure - Note 4 - Convertible Notes to Related Parties (Details Textual) </LongName>
<ReportType> Notes </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-4-convertible-notes-to-related-parties-details-textual </Role>
<ShortName> Note 4 - Convertible Notes to Related Parties (Details Textual) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 016 - Disclosure - Note 5 - Stockholders' Equity (Details Textual) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity-details-textual </Role>
<ShortName> Note 5 - Stockholders' Equity (Details Textual) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 017 - Statement - Note 5 - Stockholders' Equity - Allocation of the Recognized Cost (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity-allocation-of-the-recognized-cost-details </Role>
<ShortName> Note 5 - Stockholders' Equity - Allocation of the Recognized Cost (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 018 - Statement - Note 5 - Stockholders' Equity - Option Valuation Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity-option-valuation-assumptions-details </Role>
<ShortName> Note 5 - Stockholders' Equity - Option Valuation Assumptions (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 019 - Statement - Note 5 - Stockholders' Equity - Option Summary (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://herontx.com/20150331/role/statement-note-5-stockholders-equity-option-summary-details </Role>
<ShortName> Note 5 - Stockholders' Equity - Option Summary (Details) </ShortName>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Info"> Element hrtx_ConvertibleNotesPayableRelatedPartiesCurrent had a mix of decimals attribute values: -3 0. </Log>
<Log type="Info"> 'Monetary' elements on report '003 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> 'Monetary' elements on report '013 - Disclosure - Note 1 - Business (Details Textual)' had a mix of different decimal attribute values. </Log>
<Log type="Warning"> Warning: The equity rendering routine was not applied to 014 - Statement - Note 3 - Accounting Policies - Equity Excluded From Calculation of Diluted Earnings Per Share (Details). None of the elements feature the 'periodStartLabel' preferred label role. </Log>
<Log type="Warning"> Warning: The equity rendering routine was not applied to 017 - Statement - Note 5 - Stockholders' Equity - Allocation of the Recognized Cost (Details). None of the elements feature the 'periodStartLabel' preferred label role. </Log>
<Log type="Warning"> Warning: The equity rendering routine was not applied to 018 - Statement - Note 5 - Stockholders' Equity - Option Valuation Assumptions (Details). None of the elements feature the 'periodStartLabel' preferred label role. </Log>
<Log type="Info"> 'Shares' elements on report '019 - Statement - Note 5 - Stockholders' Equity - Option Summary (Details)' had a mix of different decimal attribute values. </Log>
<Log type="Info"> Process Flow-Through: 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Mar. 31, 2014' </Log>
<Log type="Info"> Process Flow-Through: Removing column 'Dec. 31, 2013' </Log>
<Log type="Info"> Process Flow-Through: 002 - Statement - Condensed Consolidated Statements of Operations (Unaudited) </Log>
<Log type="Info"> Process Flow-Through: 003 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) </Log>
<Log type="Info"> Process Flow-Through: 014 - Statement - Note 3 - Accounting Policies - Equity Excluded From Calculation of Diluted Earnings Per Share (Details) </Log>
<Log type="Info"> Process Flow-Through: 017 - Statement - Note 5 - Stockholders' Equity - Allocation of the Recognized Cost (Details) </Log>
<Log type="Info"> Process Flow-Through: 018 - Statement - Note 5 - Stockholders' Equity - Option Valuation Assumptions (Details) </Log>
<Log type="Info"> Process Flow-Through: 019 - Statement - Note 5 - Stockholders' Equity - Option Summary (Details) </Log>
<Log type="Info"> Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' </Log>
</Logs>
<InputFiles>
<File> hrtx-20150331.xml </File>
<File> hrtx-20150331.xsd </File>
<File> hrtx-20150331_cal.xml </File>
<File> hrtx-20150331_def.xml </File>
<File> hrtx-20150331_lab.xml </File>
<File> hrtx-20150331_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies/>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/12/24  Heron Therapeutics, Inc./DE       10-K       12/31/23   72:10M                                    Donnelley … Solutions/FA
 3/29/23  Heron Therapeutics, Inc./DE       10-K       12/31/22   73:12M                                    Donnelley … Solutions/FA
 2/28/22  Heron Therapeutics, Inc./DE       10-K       12/31/21   74:12M                                    ActiveDisclosure/FA
 2/24/21  Heron Therapeutics, Inc./DE       10-K       12/31/20   74:12M                                    ActiveDisclosure/FA
↑Top
Filing Submission 0001193125-15-179414   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 9:06:10.1pm ET